© 2001 Journal of Clinical Pathology
Acute erythremic myelosis (true erythroleukaemia): a variant of AML FAB-M6
1 Department of Histopathology, Hammersmith Hospitals NHS Trust, Du Cane Road, London W12 0NN, UK
2 Department of Haematology, Hammersmith Hospitals NHS Trust
3 Department of Haematology, St Mary's Hospital NHS Trust, Praed St, London W2 1NY, UK
Correspondence to:
Dr Hasserjian r.hasserjian{at}ic.ac.uk
AimsClassic erythroleukaemia (acute myeloid leukaemia M6, or M6 AML) is defined as an excess of myeloblasts in an erythroid predominant background. Leukaemia variants in which the primitive blast cells are demonstrably erythroid are extremely rare and poorly characterised. Variably referred to as "true erythroleukaemia" or "acute erythremic myelosis", they are often included within the M6 AML category even though they do not meet strict criteria for this type of AML.
Methods Two cases of acute erythroid neoplasia are presented with clinical, morphological, immunophenotypic, and cytogenetic analysis.
ResultsBoth patients presented with profound anaemia, one in a setting of long standing myelodysplasia. Bone marrow examination revealed a predominant population of highly dysplastic erythroid cells in both cases. In one case, the liver was infiltrated by neoplastic erythroid cells. Both patients died within four months of diagnosis.
ConclusionsThis report illustrates that cases of acute leukaemia occur in which the dominant neoplastic cell is a primitive erythroid cell without an accompanying increase in myeloblasts. This does not preclude the neoplastic clone originating in a multipotent haemopoietic stem cell, as suggested by cases arising in patients with myelodysplasia. Acute erythremic myelosis should be recognised as a distinct variant of M6 AML.
Key Words: erythroleukaemia erythremic myelosis Di Guglielmo acute leukaemia
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Mazzella, F M, Schumacher, H R
(2002). Acute erythremic myelosis (true erythroleukaemia): a variant of AML FAB-M6. J. Clin. Pathol.
55: 800-800
[Full Text] -
Vardiman, J. W., Harris, N. L., Brunning, R. D.
(2002). The World Health Organization (WHO) classification of the myeloid neoplasms. Blood
100: 2292-2302
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
